Documents
Application Sponsors
NDA 208251 | LABORATORIOS SALVAT | |
Marketing Status
Application Products
001 | SOLUTION/DROPS;OTIC | EQ 0.3% BASE;0.025% | 1 | OTOVEL | CIPROFLOXACIN HYDROCHLORIDE; FLUOCINOLONE ACETONIDE |
FDA Submissions
TYPE 5; Type 5 - New Formulation or New Manufacturer | ORIG | 1 | AP | 2016-04-29 | STANDARD |
Submissions Property Types
CDER Filings
LABORATORIOS SALVAT
cder:Array
(
[0] => Array
(
[ApplNo] => 208251
[companyName] => LABORATORIOS SALVAT
[docInserts] => ["",""]
[products] => [{"drugName":"OTOVEL","activeIngredients":"CIPROFLOXACIN HYDROCHLORIDE; FLUOCINOLONE ACETONIDE","strength":"EQ 0.3% BASE;0.025%","dosageForm":"SOLUTION\/DROPS;OTIC","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
[labels] => [{"actionDate":"04\/29\/2016","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/208251orig1s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"04\/29\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 5 - New Formulation or New Manufacturer","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/208251orig1s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/208251Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2016\\\/208251Orig1s000TOC.cfm\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2016-04-29
)
)